The recent disruptions in global distribution have highlighted the value of securing essential medications like Ivermectin. Trusting on overseas manufacturers exposes nations to significant vulnerabilities, including delivery delays, price fluctuations, and even geopolitical threats. Shifting towards domestic production of Ivermectin offers a multi